Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity
Open accessThe DOI matches its Crossref record; 68 of the 71 references it cites were found in a registry or an index.
Abstract
Recent genetic evidence supports a link between microglia and the complement system in Alzheimer's disease (AD). In this study, we uncovered a novel role for the microglial complement receptor 3 (CR3) in the regulation of soluble β-amyloid (Aβ) clearance independent of phagocytosis. Unexpectedly, ablation of CR3 in human amyloid precursor protein-transgenic mice results in decreased, rather than increased, Aβ accumulation. In line with these findings, cultured microglia lacking CR3 are more efficient than wild-type cells at degrading extracellular Aβ by secreting enzymatic factors, including tissue plasminogen activator. Furthermore, a small molecule modulator of CR3 reduces soluble Aβ levels and Aβ half-life in brain interstitial fluid (ISF), as measured by in vivo microdialysis. These results suggest that CR3 limits Aβ clearance from the ISF, illustrating a novel role for CR3 and microglia in brain Aβ metabolism and defining a potential new therapeutic target in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conversely, fibrinogen/CD11b signaling may enhance Aβ-induced neurodegeneration by suppressing Aβ clearance (Czirr et al., 2017).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Czirr et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although CR3 mediates the clearance of fibrillar and oligomeric Aβ, it might also promote the accumulation of Aβ deposits [144, 145].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [144]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Further, studies manipulating the complement system have yielded mixed results.”
The cited source says what the claim attributes to it.
In the citing paper
“The deficiency of complement factors such as C1q, C3, C3ar1, C5aR, and Cd59, has exacerbated neuropathology in some studies [84–86] and reduced neuropathology in others [87–89].”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Aβ plaque burden was decreased in the hippocampus of 5XFAD:Fggγ390–396A mice (Figure 4B).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Czirr et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089 · cited 2×
“, 2012), as well as the removal of synapses during development (Stevens et al., 2007; Schafer et al., 2012), in a model of neurodegeneration (Stevens et al.”
BackgroundComplement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 3×
“, 2012), in a model of neurodegeneration (Stevens et al., 2007) and in amyloid precursor protein (APP)–transgenic mice (Hong et al.”
BackgroundTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 1×
“…genetic support from genome-wide association studies that have identified several single nucleotide polymorphisms in immune-related genes that increase the risk of developing late onset AD (Lambert et al., 2009; Jun et al., 2010; Naj et al., 2011; Guerreiro et al., 2013; Jonsson et al., 2013).”
BackgroundVariant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 2×
“This notion has received genetic support from genome-wide association studies that have identified several single nucleotide polymorphisms in immune-related genes that increase the risk of developing late onset AD (Lambert et al., 2009; Jun et al., 2010; Naj et al., 2011; Guerreiro et al., 2013; Jonsson et al., 2013).”
BackgroundResultGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · cited 2×
“This notion has received genetic support from genome-wide association studies that have identified several single nucleotide polymorphisms in immune-related genes that increase the risk of developing late onset AD (Lambert et al., 2009; Jun et al., 2010; Naj et al., 2011; Guerreiro et al., 2013; Jonsson et al., 2013).”
BackgroundResult
Cited by
Microglia in Alzheimer’s disease
Hansen, D. V., Hanson, J. E., & Sheng, M. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709069 · Cited by 1,935
“…molecules in the brain, is present in Aβ plaques (Namba et al., 1991; Wisniewski and Frangione, 1992; Zhan et al., 1995) and contributes to both the clearance and the amyloid deposition of Aβ peptide (Bales et al., 1997a; DeMattos et al., 2004; Bien-Ly et al., 2012; Holtzman et al., 2012).”
BackgroundTissue macrophages: heterogeneity and functions
Gordon, S., & Plüddemann, A. (2017) · BMC Biology · doi:10.1186/s12915-017-0392-4 · Cited by 603
Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease
Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532
Litvinchuk, A., Wan, Y.-W., Swartzlander, D. B., Chen, F., Cole, A., Propson, N. E., Wang, Q., Zhang, B., Liu, Z., & Zheng, H. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.031 · Cited by 523
“Through an independent mechanism involving extracellular secretase activity, CR3 is shown to regulate Ab degradation (Czirr et al., 2017).”
Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy
Fakhoury, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170720095240 · Cited by 479
“aad8373] [PMID: 27033548] [50] Czirr, E.”
BackgroundMerlini, M., Rafalski, V. A., Rios Coronado, P. E., Gill, T. M., Ellisman, M., Muthukumar, G., Subramanian, K. S., Ryu, J. K., Syme, C. A., Davalos, D., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.014 · Cited by 431
“Conversely, fibrinogen–CD11b signaling may enhance Ab-induced neurodegeneration by suppressing Ab clearance (Czirr et al., 2017).”
BackgroundResultSelf-citationAlzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Zheng, Q., & Wang, X. (2025) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 410
Microglia-Mediated Synapse Loss in Alzheimer's Disease
Rajendran, L., & Paolicelli, R. C. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1136-17.2017 · Cited by 355
“While C3 deficiency seems to behoove protection against synaptic loss, even in the presence of increased A levels as described by Shi et al. (2017); Czirr et al. (2017) recently showed that C3 deletion in APP transgenic mice actually reduced phagocytic activity in microglia but increased A…”
BackgroundInfluentialBeyond the neuron–cellular interactions early in Alzheimer disease pathogenesis
Henstridge, C. M., Hyman, B. T., & Spires-Jones, T. L. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0113-1 · Cited by 348
A1/A2 astrocytes in central nervous system injuries and diseases: Angels or devils?
Fan, Y.-Y., & Huo, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105080 · Cited by 304
Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
Hemonnot, A.-L., Hua, J., Ulmann, L., & Hirbec, H. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00233 · Cited by 298
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293
“C3 deficiency reduces phagocytic activity and protects synapses from removal, but the involvement of other complement pathway-associated molecules in AD suggests the entire complement cascade is implicated (Czirr et al., 2017; Shi et al., 2017; Zorzetto et al., 2017).”
BackgroundAging Microglia—Phenotypes, Functions and Implications for Age-Related Neurodegenerative Diseases
Spittau, B. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00194 · Cited by 253
“However, lack of C3aR in APP transgenic mice results in decreased, rather than increased, Aβ deposition and C3aR-deficient microglia are more effective in degrading extracellular Aβ (Czirr et al., 2017).”
BackgroundZhang, D., Li, S., Hou, L., Jing, L., Ruan, Z., Peng, B., Zhang, X., Hong, J.-S., Zhao, J., & Wang, Q. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02065-z · Cited by 187
Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
Andronie-Cioara, F. L., Ardelean, A. I., Nistor-Cseppento, C. D., Jurcau, A., Jurcau, M. C., Pascalau, N., & Marcu, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031869 · Cited by 164
Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases
Jha, M. K., Kim, J.-H., Song, G. J., Lee, W., Lee, I. K., Lee, H., An, S. S. A., Kim, S., & Suk, K. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.12.003 · Cited by 167
“Similarly, Czirr et al. (2017) have recently identified a novel role for the microglial complement receptor 3 (CR3) in the regulation of soluble Ab clearance independent of phagocytosis (Czirr et al., 2017).”
BackgroundExercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Wang, M., Zhang, H., Liang, J., Huang, J., & Chen, N. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02753-6 · Cited by 162
Kim, E., Kim, H., Jedrychowski, M. P., Bakiasi, G., Park, J., Kruskop, J. M., Choi, Y., Kwak, S. S., Quinti, L., Kim, D. Y., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.08.012 · Cited by 150
Defining blood-induced microglia functions in neurodegeneration through multiomic profiling
Mendiola, A. S., Yan, Z., Dixit, K., Johnson, J. R., Bouhaddou, M., Meyer-Franke, A., Shin, M.-G., Yong, Y., Agrawal, A., MacDonald, E., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01522-0 · Cited by 124
Self-citationSignificance of Complement System in Ischemic Stroke: A Comprehensive Review
Ma, Y., Liu, Y., Zhang, Z., & Yang, G. (2019) · Aging and Disease · doi:10.14336/ad.2019.0119 · Cited by 133
“By contrast, a recent study uncovered a distinct mechanism of microglia-specific CR3 on modulating the Aβ levels in the brain [217].”
BackgroundThe role of innate immunity in Alzheimer's disease
Ennerfelt, H. E., & Lukens, J. R. (2020) · Immunological Reviews · doi:10.1111/imr.12896 · Cited by 119
NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer’s Disease
Sivamaruthi, B. S., Raghani, N. R., Chorawala, M. R., Bhattacharya, S., Prajapati, B. G., Elossaily, G. M., & Chaiyasut, C. (2023) · Biomedicines · doi:10.3390/biomedicines11092587 · Cited by 131
Zhao, Z., Wang, Y., Zhou, R., Li, Y., Gao, Y., Tu, D., Wilson, B., Song, S., Feng, J., Hong, J.-S., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1728-5 · Cited by 109
Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances
Deng, Q., Wu, C., Parker, E., Liu, T. C.-Y., Duan, R., & Yang, L. (2023) · Aging and disease · doi:10.14336/ad.2023.0907 · Cited by 102
Mast cells and complement system: Ancient interactions between components of innate immunity
Komi, D. E. A., Shafaghat, F., Kovanen, P. T., & Meri, S. (2020) · Allergy · doi:10.1111/all.14413 · Cited by 106
Long, H., Zhou, Z.-W., Cheng, Y., Luo, H., Li, F., Xu, S., & Gao, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.888989 · Cited by 106
Terzioglu, G., & Young-Pearse, T. L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00674-9 · Cited by 91
“Although CR3 mediates the clearance of fibrillar and oligomeric Aβ, it might also promote the accumulation of Aβ deposits [144, 145].”
BackgroundGullotta, G. S., Costantino, G., Sortino, M. A., & Spampinato, S. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119144 · Cited by 110
Luchena, C., Zuazo-Ibarra, J., Alberdi, E., Matute, C., & Capetillo-Zarate, E. (2018) · Mediators of Inflammation · doi:10.1155/2018/2530414 · Cited by 82
“Deletion of CR3 has been shown to be protective both in vitro and in vivo [8, 91].”
InfluentialA Neuron, Microglia, and Astrocyte Triple Co-culture Model to Study Alzheimer’s Disease
Luchena, C., Zuazo-Ibarra, J., Valero, J., Matute, C., Alberdi, E., & Capetillo-Zarate, E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.844534 · Cited by 82
Lamers, C., Plüss, C. J., & Ricklin, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.662164 · Cited by 84
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
Uddin, M. S., Kabir, M. T., Jalouli, M., Rahman, M. A., Jeandet, P., Behl, T., Alexiou, A. T., Albadrani, G. M., Abdel‐Daim, M. M., Perveen, A., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210826130210 · Cited by 81
“It has been confirmed through multiple studies that along with the NFTs and Aβ plaques, the presence of sustained neuroinflammatory response was observed in AD brains [21-23].”
Dysregulated Wnt Signalling in the Alzheimer’s Brain
Aghaizu, N. D., Jin, H., & Whiting, P. J. (2020) · Brain Sciences · doi:10.3390/brainsci10120902 · Cited by 70
“In addition, microglia also orchestrate plasminogen and metalloproteinase proteolytic activities to act on Aβ [219].”
BackgroundZhang, H., Zhao, Y., Yu, M., Zhao, Z., Liu, P., Cheng, H., Ji, Y., Jin, Y., Sun, B., Zhou, J., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.008 · Cited by 69
The Importance of Complement-Mediated Immune Signaling in Alzheimer’s Disease Pathogenesis
Batista, A. F., Khan, K. A., Papavergi, M.-T., & Lemere, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020817 · Cited by 65
“Furthermore, the microglial CR3 can regulate A β homeostasis via proteolytic activity, independent of phagocytosis [126].”
BackgroundLv, Z., Chen, L., Chen, P., Peng, H., Rong, Y., Hong, W., Zhou, Q., Li, N., Li, B., Paolicelli, R. C., et al. (2024) · Neuron · doi:10.1016/j.neuron.2023.12.003 · Cited by 69
Radiation Triggers a Dynamic Sequence of Transient Microglial Alterations in Juvenile Brain
Osman, A. M., Sun, Y., Burns, T. C., He, L., Kee, N., Oliva‐Vilarnau, N., Alevyzaki, A., Zhou, K., Louhivuori, L. M., Uhlén, P., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107699 · Cited by 74
Modulation of C5a–C5aR1 signaling alters the dynamics of AD progression
Carvalho, K., Schartz, N. D., Balderrama-Gutierrez, G., Liang, H. Y., Chu, S., Selvan, P., Gómez-Arboledas, Á., Petrisko, T. J., Fonseca, M. I., Mortazavi, A., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02539-2 · Cited by 64
“It is expressed exclusively on microglia in the CNS (56), and previously shown to be upregulated in AD models (57, 58).”
BackgroundGlia in Neurodegeneration: The Housekeeper, the Defender and the Perpetrator
Sheeler, C. A., Rosa, J. S., Ferro, A., McAdams, B. D., Borgenheimer, E., & Cvetanović, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239188 · Cited by 63
Role of Neuron and Glia in Alzheimer’s Disease and Associated Vascular Dysfunction
Bandyopadhyay, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.653334 · Cited by 61
Microglial Priming in Infections and Its Risk to Neurodegenerative Diseases
Lima, M. N., Barbosa‐Silva, M. C., & Maron‐Gutierrez, T. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.878987 · Cited by 71
“Furthermore, these states are characterized by constitutive expression of macrophage antigens such as complement receptor 3 (CD18/CD11b) and low expression of the major histocompatibility complex (MHC) II (Ehlers, 2000; Frank et al., 2006; Colton and Wilcock, 2010; Czirr et al., 2017).”
BackgroundComplement cascade functions during brain development and neurodegeneration
Fatoba, O., Itokazu, T., & Yamashita, T. (2021) · FEBS Journal · doi:10.1111/febs.15772 · Cited by 61
Kalinin, S., González‐Prieto, M., Scheiblich, H., Lisi, L., Kusumo, H., Heneka, M. T., Madrigal, J. L. M., Pandey, S. C., & Feinstein, D. L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1184-7 · Cited by 56
Wang, Q., Liu, J., Zhang, Y., Li, Z., Zhao, Z., Jiang, W., Zhao, J., Hou, L., & Wang, Q. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103369 · Cited by 54
“Czirr et al. found that CR3 was involved in regulating phagocytosis and clearance of β -amyloid (A β ), a main component of plaque senile in AD, by microglia [10].”
BackgroundBorucki, D. M., Toutonji, A., Couch, C., Mallah, K., Rohrer, B., & Tomlinson, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.566892 · Cited by 50
“This is in contrast with findings in more recent animal studies showing that CR3 deficiency improves microglial clearance of Aβ in vivo and in vitro by increasing enzymatic degradation (25).”
ResultFerro, A., Sheeler, C., Rosa, J.-G., & Cvetanovic, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.016 · Cited by 46
Hou, L., Qu, X., Qiu, X., Huang, R., Zhao, X., & Wang, Q. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01823-3 · Cited by 49
Ghosh, P., Singh, R., Ganeshpurkar, A., Pokle, A. V., Singh, R. B., Singh, S. K., & Kumar, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105212 · Cited by 43
Marongiu, R. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00242 · Cited by 42
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01492-x · Cited by 41
Olfactory dysfunction and its related molecular mechanisms in Parkinson’s disease
Gu, Y., Zhang, J., Zhao, X., Nie, W., Xu, X., Liu, M., & Zhang, X. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.380875 · Cited by 44
Hou, L., Zhang, L., Hong, J., Zhang, D., Zhao, J., & Wang, Q. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.8014 · Cited by 40
Proteolytic cleavage of Beclin 1 exacerbates neurodegeneration
Bieri, G., Lucin, K. M., O’Brien, C. E., Zhang, H., Villeda, S., & Wyss‐Coray, T. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0302-4 · Cited by 36
Fu, H., Liu, B., Li, L., & Lemere, C. A. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.07.020 · Cited by 37
“…anuscript A uthor M anuscript endothelin-converting enzyme (ECE-1 and ECE-2) and tissue plasminogen activator (Chu et al., 1998; Chung et al., 1999; Czirr et al., 2017; Eckman et al., 2001; Farris et al., 2007; Hernandez-Guillamon et al., 2010; Leissring et al., 2003; Mandrekar et al., 2009;…”
BackgroundAged-Related Changes in Microglia and Neurodegenerative Diseases: Exploring the Connection
Borrajo, A. (2024) · Biomedicines · doi:10.3390/biomedicines12081737 · Cited by 41
“However, the lack of C3aR in APP transgenic mice results in decreased A β deposition, suggesting a complex role of microglia in AD pathogenesis [83].”
BackgroundLu, J., Hou, L., Zhang, D., Li, S., Ruan, Z., Zhang, X., Hong, J., & Wang, Q. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s299927 · Cited by 34
PDE inhibition in distinct cell types to reclaim the balance of synaptic plasticity
Rombaut, B., Kessels, S., Schepers, M., Tiane, A., Paes, D., Solomina, Y., Piccart, E., van den Hove, D., Brône, B., Prickaerts, J., et al. (2020) · Theranostics · doi:10.7150/thno.50701 · Cited by 35
“In contrast, microglia and the complement system were initially seen as neuroprotective in AD, as the complement system counteracts amyloid plaque deposition by inducing microglial phagocytosis of Aβ [132].”
BackgroundNi, J., Xie, Z., Quan, Z., Meng, J., & Qing, H. (2023) · Glia · doi:10.1002/glia.24465 · Cited by 34
“This is in contrast with findings from more recent animal studies showing that CR3 deficiency improves the microglia-mediated clearance of A β in vivo and in vitro by increasing enzymatic degradation (Czirr et al., 2017).”
ResultXie, Z., Meng, J., Kong, W., Wu, Z., Lan, F., Narengaowa, Hayashi, Y., Yang, Q., Bai, Z., Nakanishi, H., et al. (2022) · Aging Cell · doi:10.1111/acel.13565 · Cited by 36
“We used an in vitro Aβ degradation assay system in which freshly solubilized Aβ1- 42 was added to CatE−/− and control microglial cells (cell- based assay) or their cultured medium (cell- free assay) for ELISA measurements (Czirr et al., 2017).”
MethodBello-Medina, P. C., González-Franco, D. A., Vargas-Rodríguez, I., & Díaz-Cintra, S. Y. (2021) · Neurología (English Edition) · doi:10.1016/j.nrleng.2019.06.008 · Cited by 41
Shinjyo, N., Kagaya, W., & Pekna, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.710390 · Cited by 34
Ji, Y., Ma, Y., Ma, Y., Wang, Y., Zhao, X., Jin, D., Xu, L., & Ge, S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111290 · Cited by 31
The role of integrins in brain health and neurodegenerative diseases
Cui, Y., Rõlova, T., & Fagerholm, S. C. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151441 · Cited by 36
The activation of microglia by the complement system in neurodegenerative diseases
Zhao, H., Lv, Y., Xu, J., Song, X., Wang, Q., Zhai, X., Ma, X., Qiu, J., Cui, L., & Sun, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102636 · Cited by 34
Hou, L., Liu, J., Sun, F., Huang, R., Chang, R., Ruan, Z., Wang, Y., Zhao, J., & Wang, Q. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02732-x · Cited by 32
The age-related microglial transformation in Alzheimer's disease pathogenesis
Yuan, C., Aierken, A., Xie, Z., Li, N., Zhao, J., & Qing, H. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.024 · Cited by 28
The Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
Chernyaeva, L., Ratti, G., Teirilä, L., Fudo, S., Rankka, U., Pelkonen, A., Korhonen, P., Leskinen, K., Keskitalo, S., Salokas, K., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256467 · Cited by 34
“Expression of CR3, however, has been shown to increase rather than reduce A b accumulation in vivo (Czirr et al , 2017).”
Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment
Juul‐Madsen, K., Parbo, P., Ismail, R., Ovesen, P. L., Schmidt, V., Madsen, L. S., Thyrsted, J., Gierl, S., Breum, M., Larsen, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45627-y · Cited by 36
Experimental modeling of Alzheimer's disease: Translational lessons from cross‐taxon analyses
Yenkoyan, K. B., Kotova, M. M., Apukhtin, K. V., Galstyan, D. S., Amstislavskaya, T. G., Strekalova, T. V., de Abreu, M. S., Chavushyan, V. A., Lim, L. W., Yang, L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70273 · Cited by 34
Bello-Medina, P. C., González-Franco, D. A., Vargas-Rodríguez, I., & Díaz-Cintra, S. Y. (2019) · Neurología · doi:10.1016/j.nrl.2019.06.002 · Cited by 28
Mackey-Alfonso, S. E., Butler, M. J., Taylor, A., Williams-Medina, A. R., Muscat, S. M., Fu, H., & Barrientos, R. M. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.021 · Cited by 26
“Furthermore, blocking complement protein C1q and the complement (C3) receptor increased the number of functional synapses (Hong, 2016; Shi, 2017; Czirr, 2017).”
BackgroundNeuromechanobiology: An Expanding Field Driven by the Force of Greater Focus
Motz, C. T., Kabat, V., Saxena, T. K., Bellamkonda, R. V., & Zhu, C. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100102 · Cited by 29
Synaptic Pruning in Alzheimer’s Disease: Role of the Complement System
Brucato, F. H., & Benjamin, D. E. (2020) · Global Journal of Medical Research · doi:10.34257/gjmrfvol20is6pg1 · Cited by 30
Scott‐Hewitt, N., Huang, Y., & Stevens, B. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15010 · Cited by 24
Beneficial versus Detrimental Effects of Complement–Microglial Interactions in Alzheimer’s Disease
Ayyubova, G., & Fazal, N. (2024) · Brain Sciences · doi:10.3390/brainsci14050434 · Cited by 24
“However, the studies demonstrating the harmful effects of C1q, C3, and CR3 on synaptic homeostasis have investigated the pre-plaque stages of the disease in J20 [12] and APP animals [83].”
BackgroundScreening Techniques for Drug Discovery in Alzheimer’s Disease
Maniam, S., & Maniam, S. (2024) · ACS Omega · doi:10.1021/acsomega.3c07046 · Cited by 24
C1q Regulates Horizontal Cell Neurite Confinement in the Outer Retina
Burger, C. A., Jiang, D., Li, F., & Samuel, M. A. (2020) · Frontiers in Neural Circuits · doi:10.3389/fncir.2020.583391 · Cited by 20
Wang, Q., Ruan, Z., Jing, L., Guo, Z., Zhang, X., Liu, J., Tian, L., Sun, W., Song, S., Hong, J., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115550 · Cited by 22
Tajmim, A., Cuevas-Ocampo, A. K., Siddique, A. B., Qusa, M. H., King, J. A., Abdelwahed, K. S., Sonju, J. J., & Sayed, K. A. E. (2021) · Nutrients · doi:10.3390/nu13051702 · Cited by 22
The Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
Xie, Z., Meng, J., Wu, Z., Nakanishi, H., Hayashi, Y., Kong, W., Lan, F., Narengaowa, Yang, Q., Qing, H., et al. (2023) · The Neuroscientist · doi:10.1177/10738584211070273 · Cited by 19
Jiang, M., Zhao, D., Zhou, Y., Kong, W., Xie, Z., Xiong, Y., Li, Y., Zhao, S., Kou, X., Zhang, S., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01994-0 · Cited by 28
Complement therapeutics in neurodegenerative diseases
Zelek, W. M., & Tenner, A. J. (2025) · Immunobiology · doi:10.1016/j.imbio.2025.153089 · Cited by 21
“Microglial CR3 has been suggested to regulate A β homeostasis via proteolytic mechanisms that function independently of phagocytosis (Czirr et al., 2017).”
Impaired Synaptic Plasticity Mechanisms in Alzheimer’s Disease
Ebrahimi, R., Golzari, Z., Heidari‐Foroozan, M., Khosravi, A., Sharghi, S. G., Saleh, M., Salarvandian, S., & Esmaeilpour, K. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01712-9 · Cited by 23
“In amyloidogenic models such as APP transgenic mice, it has been observed that CR3 reduces microglial phago‑ cytic activity (Czirr et al. 2017).”
Guan, P.-P., Ge, T.-Q., & Wang, P. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10076-9 · Cited by 21
“Further studies have shown that CR3 activation impairs the learning and memory ability of AD mice by inhibiting the degradation of Aβ rather than by regulating the activities of secretases (Czirr et al. 2017).”
BackgroundIn Vivo Phagocytosis Analysis of Amyloid Beta
Tejera, D., & Heneka, M. T. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9658-2_21 · Cited by 17
Microglia, synaptic dynamics and forgetting
Wang, C., Wang, L., & Gu, Y. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.06.005 · Cited by 20
Key brain cell interactions and contributions to the pathogenesis of Alzheimer’s disease
Saavedra, J., Nascimento, M., Liz, M. A., & Cardoso, I. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1036123 · Cited by 16
“Microglia and CR3 are also important in Aβ homeostasis, since CR3 ablation in APP-transgenic mice results in lower Aβ accumulation, probably due to enhanced production of Aβdegrading enzymes and improved capacity of microglia to degrade extracellular Aβ (Czirr et al., 2017).”
BackgroundHinkle, J. J., Olschowka, J. A., Williams, J. P., & O’Banion, M. K. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.12.017 · Cited by 17
Microglial Modulation in Alzheimer’s Disease: Central Players in Neuroinflammation and Pathogenesis
Hussain, M. S., Khan, Y., Fatima, R., Maqbool, M., Ramalingam, P. S., Khan, M. G., & Bisht, A. S. (2025) · Current Alzheimer Research · doi:10.2174/0115672050364292250113063513 · Cited by 18
Refining the interactions between microglia and astrocytes in Alzheimer’s disease pathology
Chen, J., Xu, S., Wang, L., Liu, X., Liu, G., Tan, Q., Li, W., Zhang, S., & Du, Y. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.033 · Cited by 17
Hemmati, S., Sadeghi, M. A., Yousefi‐Manesh, H., Eslamiyeh, M., Vafaei, A., Foroutani, L., Donyadideh, G., Dehpour, A. R., & Rezaei, N. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s258991 · Cited by 15
Latif‐Hernandez, A., Yang, T., Butler, R. R., Losada, P. M., Minhas, P. S., White, H., Tran, K. C., Liu, H., Simmons, D. A., Langness, V. F., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13857 · Cited by 14
“[129] Czirr E, Castello NA, Mosher KI, Castellano JM, Hinkson IV, Lucin KM, et al.”
BackgroundMackey-Alfonso, S. E., & Barrientos, R. M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70911 · Cited by 15
Genetic factors related to the immune system in subjects at risk of developing Alzheimer's disease
Prendecki, M., Kowalska, M., Łagan-Jędrzejczyk, U., Piekut, T., Krokos, A., Kozubski, W. P., & Dorszewska, J. (2020) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2020.02.110 · Cited by 12
“Alternately, the elimination and modulation of microglial CR3 decrease the Aβ level (Czirr et al., 2017), and C3 antagonists”
BackgroundZhou, J., Lin, S., Hu, Q., Li, X., Chen, X., Luo, L., Ye, S., Liu, W. Y., & Ye, J. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.5.7 · Cited by 11
Augusto‐Oliveira, M., Tremblay, M., & Verkhratsky, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_6 · Cited by 10
Almalki, W. H., & Almujri, S. S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155614 · Cited by 9
Ehirchiou, D., Bernabei, I., Pandian, V. D., Nasi, S., Chobaz, V., Castelblanco, M., So, A. K. L., Martinon, F., Li, X., Acha‐Orbea, H., et al. (2024) · Arthritis Research & Therapy · doi:10.1186/s13075-024-03350-5 · Cited by 10
Immune receptors and aging brain
Djurisic, M. R. (2024) · Bioscience Reports · doi:10.1042/bsr20222267 · Cited by 3
“Unexpectedly, microglial CR3 has been found to play a role in regulating levels of A β [73].”
BackgroundInfluential
Metadata
- Authors
- Czirr, E., Castello, N. A., Mosher, K. I., Castellano, J. M., Hinkson, I. V., Lucin, K. M., Baeza-Raja, B., Ryu, J. K., Li, L., Farina, S. N., Belichenko, N. P., Longo, F. M., Akassoglou, K., Britschgi, M., Cirrito, J. R., & Wyss-Coray, T.
- Affiliations
- Stanford Medicine (US)
- University of California, San Francisco (US)
- VA Palo Alto Health Care System (US)
- Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305 1
- Washington University in St. Louis (US)
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-03-15
- Volume
- 214
- Issue
- 4
- Pages
- 1081-1092
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5379986
- OpenAlex
- W2596986005
- Cited by
- 126
- References
- 71
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 26 · 2023: 20 · 2022: 9 · 2021: 16 · 2020: 17 · 2019: 9 · 2018: 7 · 2017: 5
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by-nc-sa)
- Funders
- Alexander von Humboldt Foundation
- Jane Coffin Childs Memorial Fund for Medical Research
- National Institute of Neurological Disorders and Stroke (P01 NS074969)
- National Institutes of Health
- National Institute on Aging (R01 AG042513, AG045034)
- Department of Veterans Affairs
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- microglia, complement receptor 3, CD11b/CD18, Alzheimer's disease, amyloid clearance, tissue plasminogen activator, proteolytic activity, amyloid precursor protein transgenic mice, brain interstitial fluid, complement system, small molecule modulators, therapeutic target
- MeSH terms
- Alzheimer Disease, Animals, Benzoates, Brain, Mice, Inbred C57BL, Thiohydantoins, Macrophage-1 Antigen, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Microglia, Mice, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.